Traton SE (0AA4)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 32.73 |
|---|---|
| 52-week range | 26.18 – 41.32 |
| Return, 1 month / 3 months | −6.9% / −18.2% |
| Return, 1 year / 3 years | +25.8% / +96.9% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 32.5% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 0.48M EUR |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Traton SE is a commercial vehicle group based in Munich, Germany, that builds trucks and buses through brands such as MAN, Scania, Navistar and Volkswagen Caminhões e Ônibus. It serves haulage firms, transport operators and bus companies with heavy trucks, light and medium commercial vehicles, and city and intercity buses. The group also offers connected vehicle services and digital tools for fleet management, financing and aftersales support, drawing on shared technology across its vehicle brands.
On this site Traton SE appears as a stock on the London Stock Exchange (UK), code 0AA4, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Traton SE (0AA4) trades on the London Stock Exchange in UK. It last closed at EUR 32.73 on 27 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,905 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.8% and over the last three months it fell 18.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.3% | ||
| From 52-week high | -20.3% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -18.2% | ||
| 6-month return | 4.7% | ||
| 12-month return, skipping the last month | 35.2% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.48M EUR | ||
| Zero-volume days | 13.3% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −6.9% |
| 3 months | −18.2% |
| 6 months | +4.7% |
| 1 year | +25.8% |
| 3 years | +96.9% |
| 5 years | +78.4% |
Signals
| 50-day / 200-day average | 35.59 / 33.86 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | EUR 0.9300 |
| 15 May 2025 | EUR 1.7000 |
| 14 Jun 2024 | EUR 1.5000 |
| 2 Jun 2023 | EUR 0.7000 |
| 10 Jun 2022 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.